Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
ix, 362p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Current Cancer Research. Sprache: Englisch.
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Paperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Anbieter: GreatBookPrices, Columbia, MD, USA
EUR 137,44
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: PBShop.store US, Wood Dale, IL, USA
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: Phatpocket Limited, Waltham Abbey, HERTS, Vereinigtes Königreich
EUR 126,70
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 131,42
Anzahl: 1 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 129,76
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Speedyhen LLC, Hialeah, FL, USA
Zustand: NEW.
Anbieter: GreatBookPrices, Columbia, MD, USA
EUR 150,42
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 137,76
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: New.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 144,17
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Speedyhen, Hertfordshire, Vereinigtes Königreich
EUR 116,60
Anzahl: 1 verfügbar
In den WarenkorbZustand: NEW.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 151,78
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 148,97
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Zustand: New. 2018. Hardcover. . . . . .
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 163,96
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Springer International Publishing AG, CH, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
EUR 189,91
Anzahl: 1 verfügbar
In den WarenkorbHardback. Zustand: New. Second Edition 2018.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 171,36
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 2nd edition. 636 pages. 9.25x6.10x1.46 inches. In Stock.
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. Softcover reprint of the original 2nd ed. 2018 edition NO-PA16APR2015-KAP.
Sprache: Englisch
Verlag: Springer International Publishing, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Anbieter: moluna, Greven, Deutschland
Gebunden. Zustand: New. Summarize the unique pathobiology of head and neck cancersAddresses signaling pathways and individual proteins that are important in causing or supporting the aggressive nature of head and neck cancerDiscusses the sequencing and epigen.
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. 2018. Hardcover. . . . . . Books ship from the US and Ireland.
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Zustand: New. 2018. Paperback. . . . . .
Sprache: Englisch
Verlag: Springer Nature Switzerland, 2018
ISBN 10: 3030087794 ISBN 13: 9783030087791
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Molecular Determinants of Head and Neck Cancer | Barbara Burtness (u. a.) | Taschenbuch | vi | Englisch | 2018 | Springer Nature Switzerland | EAN 9783030087791 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Anbieter: Books Puddle, New York, NY, USA
Zustand: New.
Anbieter: moluna, Greven, Deutschland
EUR 166,97
Anzahl: Mehr als 20 verfügbar
In den WarenkorbKartoniert / Broschiert. Zustand: New.
Sprache: Englisch
Verlag: Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3030087794 ISBN 13: 9783030087791
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.
Sprache: Englisch
Verlag: Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. pp. 362.
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Hervorragend. Zustand: Hervorragend | Seiten: 636 | Sprache: Englisch | Produktart: Bücher | Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.